Introduction: Cervical cancer is one of the main causes of mortality among women in Brazil, especially in the North Region, where inequalities in access to prevention and screening services are more striking. Persistent infection with the human papillomavirus (HPV) is the main etiological factor, making immunization and early detection actions essential for controlling the disease. The global strategy of the World Health Organization (WHO) proposes to eliminate cervical cancer by 2030, with targets of 90% of girls vaccinated by age 15, 70% of women screened, and 90% of lesions treated. Monitoring regional data is essential to identify barriers and guide interventions. Objectives: To analyze the trend in cervical cancer mortality in the state of Pará and relate it to HPV vaccination data and cytopathological exams between 2019 and 2023. Methods: This was a retrospective, descriptive, epidemiological study with a quantitative approach, using secondary data from Tabnet/DATASUS, the National Cancer Institute (INCA), and the Brazilian Institute of Geography and Statistics (IBGE). Age-adjusted mortality rates (per 100,000 women), the number of doses of the HPV vaccine administered, and the number of cytopathological tests (PCCU) performed in the same period were included. The data were organized into tables and analyzed using descriptive statistics. Coverage estimates were compared with the parameters established by the WHO. Results: The cervical cancer mortality rate in Pará varied over the period, with a reduction between 2019 (9.13/100,000) and 2021 (7.77/100,000), followed by an increase in 2022 (8.94/100,000) and a slight decrease in 2023 (8.51/100,000). HPV vaccination coverage, considering the target population of girls aged 9 to 14, was 36.09% in 2022, significantly below the 80% target established by the National Immunization Program . In 2022, 194,000 doses were administered to girls, representing an increase of 72% compared to the previous year, but still insufficient to achieve ideal coverage . The number of PCCU exams performed has significantly reduced: from 53,831 collections in 2019 to 16,048 in 2023, indicating a drop of approximately 70% in the period. Considering more than 2 million women of target age in the state, the rates remain critically below ideal. Conclusion: Based on the above, the data show serious gaps in primary and secondary prevention of cervical cancer in Pará, which could compromise disease control in the medium and long term. The persistently high mortality rate, low vaccination uptake and declining screening indicate the need for regionalized public policies, focusing on social and logistical barriers. Urgent interventions are essential to bring the state closer to global elimination targets.
It is with great enthusiasm that we present the Annals of the Oncology International Symposium 2025, an event that continues to solidify its significance in the oncology landscape of northern Brazil. Held in Belém, Pará, Oncology 2025 centered around the theme "The cancer control challenge: better knowing it to best facing it," dedicating itself to exploring the latest frontiers in cancer treatment and prevention.
This year, the symposium provided a deep dive into the essential role of knowledge in the fight against cancer, presenting new perspectives and scientific advancements across various areas of oncology. Renowned global experts gathered to share their most recent research and innovative approaches, offering participants a comprehensive view of the challenges faced by healthcare professionals and patients worldwide.
Presentations and discussions during the event focused on critical topics such as the use of new technologies, advancements in personalized therapies, and more effective prevention strategies. Additionally, particular attention was given to the unique challenges faced by the Amazon region, with efforts aimed at developing region-specific solutions to meet local needs.
Beyond being a high-caliber academic event, Oncology 2025 stood out as a moment for integration and professional networking, with the warm hospitality of the city of Belém offering participants a unique experience. This event became a platform for exchanging ideas, where science, culture, and humanity came together in pursuit of a common goal: to improve cancer control both in Brazil and globally.
This collection of abstracts and articles presented during the event reflects the ongoing dedication to research and the development of innovative solutions, highlighting the importance of collaboration and shared knowledge in the fight against cancer.
General Submission Guidelines:
The presenting author, who does not have to be the first author, must be registered for Oncology 2025.
Each abstract may have up to 10 authors, including the main author and co-authors.
Only original, unpublished work will be accepted.
Submissions must be related to oncology. However, project descriptions, work proposals, experience reports, and literature reviews will not be considered.
Clinical case reports are allowed, provided the abstract addresses scientific questions, details clinical observations, and includes primary scientific data.
The abstract must be written in English, but presentations may be given in Portuguese.
Abstracts must be between 300 and 500 words.
Comissão Organizadora
Comissão Científica
See Annals of Oncology 2023 at:
https://www.even3.com.br/anais/oncology-2023-international-symposium/
Complete tool for submission, evaluation and publication of proceedings for scientific events.
